Fig. 5From: A randomized, controlled trial evaluating the efficacy and safety of BTH1677 in combination with bevacizumab, carboplatin, and paclitaxel in first-line treatment of advanced non-small cell lung cancerOverall survival. The Kaplan-Meier overall survival (months) curve from patients in the safety population. X indicates censored patients. Abbreviations: CI confidence interval, n number of patients, HR hazard ratioBack to article page